Track: Neuro-Oncology

Neuropsychiatry 2025

The "Neuro-Oncology" track provides an in-depth exploration of the diagnosis, treatment, and management of tumors affecting the central and peripheral nervous systems. This session highlights cutting-edge research, innovative therapies, and interdisciplinary approaches that are transforming the landscape of neuro-oncology. Participants will engage with experts to discuss advancements in diagnostics, targeted therapies, and supportive care that improve patient outcomes and quality of life.

Primary Brain Tumors:
This session covers the classification, diagnosis, and treatment of primary brain tumors, including gliomas, meningiomas, medulloblastomas, and ependymomas. Discussions will focus on advancements in molecular profiling, personalized treatment approaches, and the integration of surgery, radiation, and chemotherapy in management plans.

Paediatric Neuro-Oncology:
This topic emphasizes the unique aspects of brain and spinal tumors in children, such as medulloblastomas, pilocytic astrocytomas, and diffuse intrinsic pontine gliomas (DIPG). Discussions will include genetic and epigenetic factors, proton beam therapy, and supportive care strategies to optimize developmental outcomes.

Glioblastoma: Challenges and Breakthroughs:
This segment focuses on glioblastoma, one of the most aggressive brain tumors, highlighting recent progress in immunotherapy, tumor-treating fields (TTF), and novel agents targeting the tumor microenvironment. Participants will explore ongoing clinical trials and emerging molecular targets.

Advances in Surgical Neuro-Oncology:
This session explores technological innovations in neurosurgery, such as fluorescence-guided surgery, intraoperative MRI, and robotic-assisted techniques. The discussion will center on maximizing tumor resection while preserving neurological function.

Radiation and Chemotherapy Innovations:
Participants will learn about the latest advances in radiation therapy techniques, including stereotactic radiosurgery and proton therapy, as well as the development of chemotherapeutic agents that cross the blood-brain barrier. Strategies for minimizing side effects and enhancing efficacy will also be discussed.

Immunotherapy in Neuro-Oncology:
This topic examines the role of immunotherapy, including immune checkpoint inhibitors, CAR T-cell therapy, and cancer vaccines, in treating brain and spinal tumors. Discussions will focus on the challenges of overcoming the immunosuppressive tumor microenvironment and the potential for combination therapies.

Tumor Biomarkers and Molecular Diagnostics:
This session highlights the importance of molecular biomarkers in tumor classification, prognosis, and therapy selection. Topics include liquid biopsy advancements, next-generation sequencing, and the integration of biomarkers into clinical practice.

This track provides a comprehensive understanding of neuro-oncology, offering actionable knowledge to enhance clinical practice, foster research collaborations, and improve the overall care and outcomes for patients with neurological tumors.